BRISTOL, Tenn., Oct. 17 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the company plans to announce earnings for
the third quarter ending September 30, 2003, prior to the market open on
Tuesday, October 28, 2003. The Company will provide a live webcast of its
conference call to be held following King's announcement of earnings for the
third quarter.
Interested persons may listen to the live conference call on Tuesday,
October 28, 2003, at 11:00 a.m., ET at
http://www.firstcallevents.com/service/ajwz391462151gf12.html or by dialing
800-867-2186 (US only) or 785-832-2422 (international), passcode KG. If you
are unable to participate during the live webcast, the call will be archived
on King's web site http://www.kingpharm.com for not less than 30 days following the
call. A replay of the conference call will also be available for not less
than 30 days following the call by dialing 800-938-1602 (US only) or
402-220-1548 (international).
(Minimum requirements to listen to the broadcast: The Windows Media Player
software, downloadable free from
http://www.microsoft.com/windows/windowsmedia/EN/default.asp, and at least a
28.8 Kbps connection to the Internet. If you experience problems listening to
the broadcast, send an email to webcastsupport@tfprn.com)
King, headquartered in Bristol, Tennessee, is a vertically integrated
pharmaceutical company that develops, manufactures, markets, and sells branded
prescription pharmaceutical products. King, an S&P 500 Index company, seeks
to capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the third quarter ending September 30, 2003
and the live webcast of the conference call following the release. These
forward-looking statements involve certain significant risks and
uncertainties, and actual results may differ materially from the forward-
looking statements. Some important factors which may cause results to differ
include: dependence on King's ability to release the Company's financial
results for third quarter ending September 30, 2003 and conduct its conference
call as currently planned on October 28, 2003. Other important factors that
may cause actual results to differ materially from the forward-looking
statements are discussed in the "Risk Factors" section and other sections of
King's Form 10-K for the year ended December 31, 2002 and Form 10-Q for the
second quarter ended June 30, 2003, which are on file with the Securities and
Exchange Commission. King does not undertake to publicly update or revise any
of its forward-looking statements even if experience or future changes show
that the indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Audio:http://www.firstcallevents.com/service/ajwz391462151gf12.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, of King Pharmaceuticals, Inc., +1-423-989-8125
|
